Characteristics of adverse reactions of three anti-glioma drugs in WHO-VigiAccess
There is limited correlation between antineoplastic medications and ADRs. Current comparative observational studies indicate that these inhibitors are associated with both common and specific adverse effects documented in the ADR reports submitted to the World Health Organization (WHO).
Authors
- Qian Guo (ORCID: https://orcid.org/0000-0002-1211-6436)
- Suming Chen (ORCID: https://orcid.org/0000-0002-8017-0282)
- Haibo Ke (ORCID: https://orcid.org/0000-0003-3657-0403)
- Baiquan Zhang
- Qiang Zhou (ORCID: https://orcid.org/0000-0002-7678-0563)
- Xiaohui Lou
- Zicheng Zhang (ORCID: https://orcid.org/0000-0002-9553-7358)
- Yu Zhao (ORCID: https://orcid.org/0000-0003-0831-3784)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Harbin Medical University (CN)
- Wenzhou Medical University (CN)
- Ruian People's Hospital (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-10-24
- DOI
- https://doi.org/10.3389/fphar.2024.1485067
- Citations
- 10
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.38